A child with BK virus infection: Inadequacy of current therapeutic strategies

Pediatric Transplantation

Volumn 16, Issue 7, 2012, Pages

  Pereira, Tanya ^a   Rojas, Claudia P ^a   Garcia Buitrago, Monica T ^a   Chandar, Jayanthi ^a   Abitbol, Carolyn ^a   Seeherunvong, Wacharee ^a   Rusconi, Paolo ^a   Bruce, Jocelyn H ^a   Zilleruelò, Gaston ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac transplantation; immunocompromised host; renal failure; viral infection

Indexed keywords

ALBUMIN; BICARBONATE; CALCINEURIN INHIBITOR; CANDESARTAN; CIDOFOVIR; CREATININE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; VIRUS DNA;

ANTIHYPERTENSIVE THERAPY; ANTIVIRAL THERAPY; ARTICLE; AUTOPSY; BK VIRUS INFECTION; CARDIAC GRAFT REJECTION; CARDIOMEGALY; CASE REPORT; CHILD; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TUBULE ACIDOSIS; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PODOCYTE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTEINURIA; RENAL PROTECTION; RESPIRATORY FAILURE; STEROID THERAPY; VIRUS LOAD;

BK VIRUS; BRAIN DISEASES; CARDIOMYOPATHIES; CHILD; CYTOSINE; ENCEPHALOMYELITIS; FATAL OUTCOME; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; ORGANOPHOSPHONATES; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; VIRAL LOAD;

EID: 84866729883     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01602.x     Document Type: Article

References (33)

1. Ojo AO, Held PJ, Port FK, et al., Chronic renal failure after transplantation of a non-renal organ. N Engl J Med 2003: 349: 931-940.
2. Schwarz A, Menzel M, Haller H, Neidermeyer J,. Polyomavirus nephropathy in native kidneys after lung transplantation. Am J Transplant 2005: 5: 2582-2585.
3. Ali FN, Meehan SM, Pahl E, Cohn RA,. Native BK viral nephropathy in a pediatric heart transplant recipient. Pediatr Transplant 2009: 14: E38-E41.
4. Sahney S, Yorgin P, Zuppan C, Cutler D, Kambham N, Chinnock R,. BK virus nephropathy in the native kidneys of a pediatric heart transplant recipient. Pediatr Transplant 2009: 14: E11-E15 (5).
5. Gardner SD, Mackenzie EF, Smith C, Porter AA,. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984: 37: 578-586.
6. Chesters PM, Heritage J, Mccance DJ,. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983: 147: 676-684.
7. Binet I, Nickeleit V, Hirsch HH, et al., Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999: 67: 918-922.
8. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP,. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005: 68: 1834-1839.
9. Viscount HB, Eid AJ, Griffin MD, Smith TF, Razonable R,. Polyomavirus PCR as a surrogate marker of polyomavirus associated nephropathy. Transplantation 2007: 84: 340-345.
10. Reploeg MD, Storch GA, Clifford DB,. BK virus: A clinical review. Clin Infect Dis 2001: 33: 191-202.
11. Stewart S, Winters GL, Fishbein MC, et al., Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005: 24: 1710-1720.
12. Hockett RD, Kilby JM, Derdeyn CA, et al., Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 1999: 189: 1545-1554.
13. Friedman DP, Flanders AE,. MR imaging of BK virus encephalitis. AJNR Am J Neuroradiol 2006: 27: 1016-1018.
14. Behre G, Becker M, Christopeit M,. BK virus encephalitis in an allogeneic hematopoietic stem cell recipient. Bone Marrow Transplant 2008: 42: 499.
15. Vago L, Cinque P, Sala E, et al., JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol 1996: 12: 139-146.
16. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y,. BK virus encephalitis in a patient with AIDS and lymphoma. AIDS 2001: 15: 1196-1199.
17. Vallbracht A, Lohler J, Gossmann J, et al., Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993: 143: 29-39.
18. Bratt G, Hammarin AL, Grandien M, et al., BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999: 13: 1071-1075.
19. Stoner GI, Alappan R, Jobes DV, Ryschewitsch CF, Landry ML,. BK virus regulatory region rearrangement in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis. Am J Kidney Dis 2002: 39: 1102-1112.
20. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Boninton A,. BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis. Infection 2003: 31: 374-378.
21. Voltz R, Jager G, Seelos K, Fuhry L, Hohlfeld R,. BK virus encephalitis in an immunocompetent patient. Arch Neurol 1996: 53: 101-103.
22. K idney D isease: I mproving G lobal O utcomes (KDIGO) T ransplant W ork G roup. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009: 9 (Suppl 3): S1-S157.
23. Hirsch HH, Brennan DC, Drachenberg CB, et al., Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005: 79: 1277-1286.
24. Sessa A, Esposito A, Gilberti A, et al., BKV reactivation in renal transplant recipients: Diagnostic and therapeutic strategyâCase reports. Transplant Proc 2008: 40: 2055-2058.
25. Hirsch HH, Randhawa P,. BK virus in solid organ recipients. Am J Transplant 2009: 9 (Suppl 4): S136-S146.
26. Loeches B, Valerio M, Palomo J, Bouza E, Munoz P,. BK virus in heart transplant recipients: A prospective study. J Heart Lung Transplant 2011: 30: 109-111.
27. Bennett WM, Meyer L, Ridenour J, Batiuk TD,. Surveillance and modification of immunosuppression minimizes BK virus nephropathy. Am J Nephrol 2010: 32: 10-12.
28. Dall A, Hariharan S,. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008: 3 (Suppl 2): S68-S75.
29. Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA,. Treatment of polyomavirus infection in kidney transplant recipients: A systematic review. Transplantation 2010: 89: 1057-1070.
30. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR,. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 2008: 12: 790-795.
31. Wu SW, Chang HR, Lian JD,. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2008: 24: 1034-1038.
32. Williams JW, Mital D, Chong A, et al., Experiences with Leflunomide in solid organ transplantation. Transplantation 2002: 73: 358-366.
33. Leca N,. Leflunomide use in renal transplantation. Curr Opin Organ Transplant 2009: 14: 370-374.